DALLAS, Dec. 13, 2011 (GLOBE NEWSWIRE) -- MicroStockProfit.com announces a stock report featuring OXiGENE Inc. (Nasdaq:OXGN). The report details the company's most recent developments and news, outlines its financial position and market performance, and includes an easy-to-read stock chart.
MicroStockProfit.com is the premier destination for investment information, making your trading decisions easier than ever. Get the rundown on how OXGN stacks up against its competitors and check-out the stock's technical data by viewing the free, in-depth report for OXGN at: http://www.microstockprofit.com/lp/OXGN
This newsletter has been helping traders make great investment decisions on OXGN; click here for a 15% discount offer.
In the report, the analyst notes:
"Shares of OXGN spiked as much as 35.6% in Monday trade, boosted by news the Company has established a partnership agreement with Azanta Danmark A/S to provide access to ZYBRESTAT for the treatment of patients in Europe and Canada with anaplastic thyroid cancer (ATC) on a compassionate use basis.
"Both companies will cooperate on regulatory activities relating to ZYBRESTAT for the treatment of ATC within the territory."
To read the entire report visit: www.microstockprofit.com/lp/OXGN
See what investors are saying about OXGN at http://www.stockhideout.com
Get breaking news on OXGN at http://thestockmarketwatch.com/
MicroStockProfit.com is a small-cap research and investment commentary provider. MicroStockProfit.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. Please visit http://www.microstockprofit.com for more information.
MicroStockProfit.com Disclosure
MicroStockProfit.com is not a registered investment advisor; nothing contained in any materials should be construed as a recommendation to buy or sell any securities. MicroStockProfit.com is a Web site wholly owned by BlueWave Advisors, LLC. Neither MicroStockProfit.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. Please read our report and visit our Web site, MicroStockProfit.com, for complete risks and disclosures.